Clinical Trials on Hyperparathyroidism, Primary
Total 59688 results
-
Josep M CruzadoCompletedSecondary HyperparathyroidismSpain
-
Mario Negri Institute for Pharmacological ResearchCompletedRenal Transplant | Secondary HyperparathyroidismItaly
-
Mersin UniversityCompletedSecondary Hyperparathyroidism | Myocardial DysfunctionTurkey
-
Wenhu LiuUnknownSecondary Hyperparathyroidism | Maintenance HemodialysisChina
-
Hospital Regional 1o de OctubreUniversidad Nacional Autonoma de Mexico; National Polytechnic Institute, MexicoCompletedHyperparathyroidism, Primary | Hyperparathyroidism, Secondary | Hypovitaminosis D | Postmenopause | Postmenopausal OsteoporosisMexico
-
University Hospital, RouenInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedParathyroid Hormone Suppression Test With CinacalcetFrance
-
University of Maryland, BaltimoreCompletedSecondary HyperparathyroidismUnited States
-
Papageorgiou General HospitalCompletedSecondary Hyperparathyroidism
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityCompletedSecondary Hyperparathyroidism | Parathyroid Gland DiseaseChina
-
OPKO Health, Inc.WithdrawnSecondary Hyperparathyroidism (SHPT) | Stage 5 Chronic Kidney Disease (CKD) | Hemodialysis (HD)
-
KAI PharmaceuticalsNucleus Network LtdCompletedHyperparathyroidism, SecondaryAustralia
-
Emory UniversityTerminatedHyperparathyroidism, SecondaryUnited States
-
AbbottCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease, Stage 5United States
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismKorea, Republic of, Taiwan, Hong Kong, China, India, Malaysia
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, SecondaryUnited States, Germany, United Kingdom
-
Benha UniversityNew Jeddah Clinic HospitalCompletedDiabetic Nephropathies | Secondary Hyperparathyroidism
-
The University of Hong KongAbbVieUnknownSecondary Hyperparathyroidism | Endstage Renal DiseaseHong Kong
-
AbbVie (prior sponsor, Abbott)CompletedChronic Kidney Disease | Secondary HyperparathyroidismGreece
-
AbbottCompletedHemodialysis | Chronic Kidney Disease | Secondary HyperparathyroidismUnited States, Czech Republic, Denmark, Germany, Greece, Italy, Netherlands, Portugal, Russian Federation, Spain, Sweden, United Kingdom
-
ENRICO VERRINAUnknownSecondary HyperparathyroidismItaly
-
AbbottCompletedHemodialysis | Secondary HyperparathyroidismJapan
-
Thomas HopeCompletedHyperparathyroidism, PrimaryUnited States
-
Roxane LaboratoriesCompletedHypocalcemia | Secondary HyperparathyroidismUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingVitamin D Deficiency | Chronic Kidney Disease 5D | Secondary Hyperparathyroidism Due to Renal CausesChina
-
AmgenTerminatedHyperparathyroidism | Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary | Kidney DiseaseUnited States, Belgium, Hungary, Spain, Australia, Germany, Poland, Mexico, Russian Federation, Slovakia
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States, Italy, Belgium, Denmark, Switzerland, Canada, Turkey, Spain, Austria, Germany, Hungary, Greece, France, Poland, Russian Federation, Czechia, Latvia, Lithuania, New Zealand, Portugal, Sweden, Estonia
-
AbbVie (prior sponsor, Abbott)Assign Data Management and Biostatistics GmbHCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease Stage V | Cardiac MorbidityAustria
-
AbbVie (prior sponsor, Abbott)CompletedHemodialysis | Secondary HyperparathyroidismJapan
-
AbbottAbbott Japan Co.,LtdCompletedHemodialysis | Secondary HyperparathyroidismJapan
-
Thomas HopeRecruitingHyperparathyroidism, PrimaryUnited States
-
Chengdu Suncadia Medicine Co., Ltd.Not yet recruiting
-
AbbVie (prior sponsor, Abbott)CompletedEvaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)Chronic Kidney Disease | Secondary HyperparathyroidismBulgaria, Czech Republic, Romania
-
University of VirginiaWithdrawnChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Kidney Disease
-
OPKO IP Holdings II, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal InsufficiencyUnited States
-
AmgenCompleted
-
AbbottCompletedSecondary Hyperparathyroidism | Chronic Kidney FailureGreece
-
OPKO Health, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Vitamin D InsufficiencyUnited States
-
Mahidol UniversityCompletedEnd Stage Renal Disease | Secondary HyperparathyroidismThailand
-
University of Sao Paulo General HospitalUnknownChronic Kidney Disease | Secondary HyperparathyroidismBrazil
-
Genzyme, a Sanofi CompanyCompletedRenal Failure | Secondary Hyperparathyroidism | Chronic Renal InsufficiencyUnited States, Puerto Rico
-
AmgenCompletedSecondary HyperparathyroidismUnited States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
-
AmgenCompletedEnd Stage Renal Disease | Secondary Hyperparathyroidism
-
AbbVie (prior sponsor, Abbott)CompletedEnd Stage Renal Disease | Secondary HyperparathyroidismTurkey
-
AmgenCompletedEnd Stage Renal Disease | Secondary Hyperparathyroidism
-
Chulalongkorn UniversityCompletedHyperparathyroidism, SecondaryThailand
-
TheraclionWithdrawnEnd Stage Renal Disease | Secondary Hyperparathyroidism | Parathyroid HyperplasiaSpain, Italy
-
Washington University School of MedicineAbbott; NorthShore University HealthSystem; Northwestern University Feinberg... and other collaboratorsCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
AmgenCompletedEnd Stage Renal Disease | Secondary Hyperparathyroidism